Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of docetaxel plus nedaplatin with docetaxel plus cisplatin
in managment of advanced/relapsed squamous cell lung cancer.